PolyPid LtdNASDAQ:PYPD
- LAST PRICE4.3000
- TODAY'S CHANGE (%)-0.1400 (-3.1532%)
- Bid / Lots4.1500/ 1
- Ask / Lots4.7500/ 3
- Open / Previous Close4.4400 / 4.4400
- Day Range
- 52 Week Range
- Volume5,248
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PYPD |
|---|---|---|
| 09:59 ET | 458 | 4.48 |
| 10:03 ET | 200 | 4.4799 |
| 10:26 ET | 150 | 4.44 |
| 11:00 ET | 500 | 4.5 |
| 11:20 ET | 1000 | 4.4889 |
| 11:49 ET | 757 | 4.4889 |
| 12:02 ET | 100 | 4.425 |
| 01:28 ET | 224 | 4.4205 |
| 01:39 ET | 411 | 4.3 |
| 02:18 ET | 420 | 4.3 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
PolyPid Ltd | 21.3M | -0.2x | --- |
Earth Science Tech Inc | 20.5M | 70.8x | --- |
KALA BIO Inc | 19.3M | -0.4x | --- |
China Health Industries Holdings Inc | 19.2M | -12.7x | --- |
PharmaCyte Biotech Inc | 17.9M | -1.3x | --- |
I-Mab | 146.1M | -0.8x | --- |
Company Information
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
Contact Information
- Headquarters
- 18 Hasivim Street, P.O Box 7126PETAH TIKVA, Israel 4917002
- Phone
- ---
- Fax
- ---
Executives
- Independent Chairman of the Board
- Jacob Harel
- Chief Executive Officer, Director
- Amir Weisberg
- Chief Financial Officer, Executive Vice President
- Dikla Akselbrad
- Chief Operating Officer, Executive Vice President
- Shaul Mukhtar
- Senior Vice President - Research and Development and Regulatory Affairs
- Dalit Hazan
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $21.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 4.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.37 |
EPS | $-19.44 |
Book Value | $-1.27 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
